Company Filing History:
Years Active: 2023
Title: Eun-Jin Lee: Innovator in Bone Regeneration Technology
Introduction
Eun-Jin Lee is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of biomedical engineering, particularly in the area of bone regeneration. His innovative work focuses on developing advanced materials that can aid in the healing and regeneration of bone tissue.
Latest Patents
Eun-Jin Lee holds a patent for "Three-dimensional printed hydroxyapatite composite scaffolds for bone regeneration, precursor compositions and methods of printing." This patent describes a three-dimensional, biocompatible scaffold precursor composition designed for room-temperature printing. The composition includes a solid phase made up of tetracalcium phosphate (TTCP) and dicalcium phosphate anhydrous (DCPA), combined with a liquid phase that contains a polymer in a solvent. The solvent can be either Ethanol (EtOH) or Tetrahydrofuran (THF), while the polymer may include polyvinyl butyral (PVB), polycaprolactone (PCL), or poly lactic-co-glycolic acid (PLGA). The printing process occurs at room temperature in an aqueous phosphate (NaHPO) bath, which acts as a hardening accelerator, resulting in the formation of the polymer/hydroxyapatite composite scaffold. Eun-Jin Lee has 1 patent to his name.
Career Highlights
Eun-Jin Lee is currently associated with Ada Science and Research Institute LLC, where he continues to advance his research in innovative materials for medical applications. His work is pivotal in developing solutions that can significantly improve patient outcomes in bone repair and regeneration.
Collaborations
Eun-Jin Lee collaborates with talented individuals in his field, including Stella Alimperti and Yoontae Kim. These collaborations enhance the research and development of new technologies in the biomedical sector.
Conclusion
Eun-Jin Lee's contributions to the field of bone regeneration through his innovative patent and ongoing research at Ada Science and Research Institute LLC highlight his commitment to advancing medical technology. His work is essential for the future of regenerative medicine.